financetom
Business
financetom
/
Business
/
Faraday Future Enters UAE Market Through Exclusive Deal
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Faraday Future Enters UAE Market Through Exclusive Deal
Oct 24, 2025 5:44 AM

Faraday Future Intelligent Electric Inc. ( FFAI ) shares are trading higher premarket on Friday after the company disclosed a deal for official entry into the United Arab Emirates (UAE) market.

FFAI shares are trending higher. Find out why here

The company penned a strategic cooperation with RAK Motors, an automotive dealer based in Ras Al Khaimah, one of the emirates in the UAE.

As an experienced automotive distributor representing major global brands like Toyota ( TM ) and Nissan (NASDAQ-SMALL:NSANY) , RAK Motors will serve as Faraday Future’s exclusive agent in the UAE for up to one year.

Also Read: EXCLUSIVE: Faraday Future Wants A Tesla-Style Breakout—And Mariah Carey’s Already Driving

Partnership Details

This partnership authorizes RAK Motors to handle the sales, delivery, and after-sales service for the FX Super One within the UAE region.

These responsibilities include managing displays, test drives, delivery, and providing full customer care, all under the close direction of FF.

This cooperation is a significant milestone for FF, as it establishes a full, end-to-end ecosystem in the UAE for the FX Super One, covering everything from production to service.

FF Executive Vice President and Head of UAE, Tin Mok added,

“The Middle East will serve as a critical springboard for FF and FX’s future expansion into Europe, Africa, and other global markets.”

Recent Key Events

Last week, the company achieved a major production milestone for the FX Super One. It signed the procurement agreement for the first batch of complete parts, and shipment is starting immediately.

Price Action: FFAI shares are up 2.08% at $1.470 premarket at the last check on Friday.

Read Next:

Qualigen Therapeutics (QLGN) Stock Soars 62% After-Hours On Partnership With BitGo To Build Multi-Asset Crypto Treasury

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Tesla's Germany Plant Could Have Power Restored as Early as Monday After Arson Attack
Tesla's Germany Plant Could Have Power Restored as Early as Monday After Arson Attack
Mar 11, 2024
07:31 AM EDT, 03/11/2024 (MT Newswires) -- Tesla's (TSLA) factory outside Berlin could be up and running sooner than expected after a March 5 arson attack on the site's power supply halted production, an official told public radio in a report aired on Monday. Regional economy minister Jorg Steinbach said that utility workers have been operating in three shifts to...
--B. Riley Securities Raises MoneyLion's PT to $127 From $102 After 'Stellar' Q4 2023 Results, Q1 2024 Guide; Maintains Buy Rating
--B. Riley Securities Raises MoneyLion's PT to $127 From $102 After 'Stellar' Q4 2023 Results, Q1 2024 Guide; Maintains Buy Rating
Mar 11, 2024
07:36 AM EDT, 03/11/2024 (MT Newswires) -- (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us) Price: 74.47, Change: -0.02, Percent Change: -0.03 ...
Endeavour Silver's Q4 2023 Adjusted EPS Falls YOY
Endeavour Silver's Q4 2023 Adjusted EPS Falls YOY
Mar 11, 2024
07:33 AM EDT, 03/11/2024 (MT Newswires) -- Endeavour Silver Corp. ( EXK ) reported Monday an adjusted EPS of US$0.02 in the fourth quarter of 2023, declining 50% year over year from US$0.04. Revenue fell 38% to US$50.5 million while silver equivalent production sank 18% to 2.2 million ounces. For full-year 2023, the miner's adjusted EPS plummeted to US$0.01 from...
Legend Biotech Q4 Loss Narrows, Revenue Rises
Legend Biotech Q4 Loss Narrows, Revenue Rises
Mar 11, 2024
07:32 AM EDT, 03/11/2024 (MT Newswires) -- Legend Biotech ( LEGN ) reported a Q4 loss Monday of $0.40 per diluted share, compared with a loss of $0.41 a year earlier. Analysts polled by Capital IQ expected a loss of $0.30. Total revenue for the quarter ended Dec. 31 was $79.5 million, up from $27.6 million a year earlier. Analysts...
Copyright 2023-2026 - www.financetom.com All Rights Reserved